Authors


Sara J. Becker, MA

Latest:

Cognitive-Behavioral Therapy for Adolescent DepressionProcesses of Cognitive Change

The substantial and often recurrent distress and impairment associated with major depressive disorder (MDD) in youth has prompted increased interest in the identification and dissemination of effective treatment models. Evidence supports the use of several antidepressant medications, specific psychotherapies, and, in the largest treatment study of depressed teenagers, the combination of fluoxetine and cognitive-behavioral therapy (CBT) as effective treatments.1-3 CBT is the most extensively tested psychosocial treatment for MDD in youth, with evidence from reviews and meta-analyses that supports its effectiveness in that population.3-5


Sara Selis

Latest:

Complementary Therapies for Schizophrenia: Expanding the Clinician’s Toolbox

Given the burdens of living with schizophrenia, and the increasing focus on patients' quality of life, it’s no wonder clinicians are seeking other treatment options for the disorder. Here, a discussion of the most promising nonconventional therapies and how to use them.


Sara Siris Nash, MD

Latest:

Psychiatric Manifestations of HIV Infection and AIDS

Patients with HIV infection are at risk of developing psychiatric symptoms and disorders similar to those seen in the general population. What unique biological, psychological and environmental factors are involved in treating this population?


Sara West, MD

Latest:

Between Stoned and a Hard Place? Navigating Cannabis Medicolegal Issues

Given the significant variation in medical cannabis laws amongst states and the continually shifting legal landscape regarding its use, medical cannabis presents a unique challenge for medical professionals who consider recommending it to their patients


Sarah H. Lisanby, MD

Latest:

Promising Strategies for Treatment-Resistant Depression

In this CME, review novel, currently available, and promising pharmacological treatment options for treatment-resistant depression.


Sarah Mourra, MD

Latest:

Sexualized Transference in Older Adults

Of all the transferences that emerge in the consultation room, sexual feelings are by far the least talked about and the most challenging for therapists to manage. This author talks about erotic transferences here.


Sarah N. Mourra, MD

Latest:

Sexuality in Older Adults: Addressing the Elephant in the Room

Recognition, management, and understanding of the broad range of sexual feelings in older adults is a key component to providing humane and competent care. More in this expert Q&A.


Sarah Nagle-Yang, MD

Latest:

Effective Note-Writing: A Primer for Psychiatry Residents

An overview of various aspects of taking notes and suggestions for effective documentation.


Sarah Rivelli, MD

Latest:

Collaborating With Our Medical Colleagues

Ninety percent of patients with psychiatric disorders are seen in the general medical sector. Two-thirds of these patients receive no treatment for their psychiatric illness. Of the one-third that does, only one-tenth is provided minimally adequate treatment.1 Furthermore, nontreatment or nonevidence-based treatment of psychiatric disorders in the primary care setting is associated with at least double the total health care costs for patients, mainly from increased general medical care and nonpsychiatric prescriptions.2,3


Sarah W. Book, MD

Latest:

The Diagnosis and Treatment of Substance Abuse/ Dependence and Co-Occurring Social Anxiety Disorder

Social anxiety disorder and drug addiction commonly co-occur in the same individual, complicating the presentation, course and treatment of both disorders. Using drugs or alcohol may be a coping mechanism for social anxiety; however, many treatments for addiction are group-based approaches, which would be especially challenging for people with social anxiety disorder. This article provides a brief overview of what is known about the co-occurrence of these disorders, as well as possible treatment interventions for this population.


Sarghi Sharma, MD

Latest:

Do Adolescents Mimic Psychiatric Symptoms of Their Virtual Friends?

Many adolescents have taken to the Internet to discuss their struggles with psychiatric disorders not ordinarily diagnosed in persons under 18 years old (eg, bipolar disorder).


Saul Levine, MD

Latest:

Ubuntu and Shalom: An Octogenarian, Psychiatrist Looks Back, and Forward

“…Have We really Changed after Lo, these Many Years?”


Saundra Jain, MA, PsyD, LPC

Latest:

Podcast: CPT Coding-When Meeting With Parents of an Adolescent Patient

Which CPT billing codes should you use when working with adolescents if there's a need for a clinician to meet with parents separately? Here to discuss is Dr Saundra Jain.


Savannah Marie

Latest:

Society’s Chemical Noose: A Look at Substance Abuse and Suicide

Substance abuse and addiction are commonly associated with an increased risk of suicide. Alcohol abuse plays a key role in suicide attempts and completions; prescription drugs are a close second. The causes of suicide for men and women are different but the suicide rates are equally staggering.


Savio Holanda Amaro

Latest:

3D Image of a Fetal Omphalocele

Onfalocele image in 3D-Fetus at 30 weeks gestation.


Sayeh Beheshti, MD, MA

Latest:

Controversies of Using Buprenorphine for Maintenance in Opioid Dependency

The use of buprenorphine for the treatment of opioid dependence is on the rise. However, buprenorphine withdrawal has its own withdrawal symptoms that in many cases can be as severe as symptoms of opioid withdrawal.


Scott A. Irwin, MD, PhD

Latest:

Attending to the “Mental Suffering” of Patients With Progressive Medical Illness

Psychiatrists have found ways to bring their expert skills and knowledge to the care of medically ill patients who are nearing the final phase of life.


Scott Bresler, PhD

Latest:

Assessing Violence Risk in Psychiatric Inpatients: Useful Tools

Psychiatrists who work in inpatient units are faced with daily decisions about predicting which patients will be violent, both in the hospital and after discharge. These decisions are often made using unstructured clinical judgment based on the clinician's experience and knowledge of the literature. How long such judgment stays the standard of care remains to be seen, because psychiatric researchers have produced a number of assessment and management tools to improve the accuracy and use of violence risk assessment. This article briefly outlines 3 tools: the Brøset Violence Checklist (BVC), the Classification of Violence Risk (COVR), and the Historical Clinical Risk-20 (HCR-20).


Scott E. Walker, MScPhm

Latest:

Irreversible Monoamine Oxidase Inhibitors Revisited

Given the likelihood that insufficient numbers of patients will be available for a randomized controlled trial of MAOIs in refractory depression or atypical depression, we must still rely on consensus guidelines and expert opinion.


Scott Shannon, MD

Latest:

6 Myths About Integrative Psychiatry

As we shift from treating disease and toward supporting health, medication is merely one possible intervention in a spectrum of possible ones.


Scott Stuart, MD

Latest:

Perinatal Psychiatry: What We Still Don't Know

A number of highly publicized cases in the lay press have underscored the significance of, and dangers associated with, perinatal psychiatric illness. Unfortunately, the field of psychiatry has failed to use these tragic cases to disseminate accurate information and educate the public about the high frequency of perinatal depression and anxiety, as well as the relative rarity of postpartum psychosis and infanticide. Moreover, psychiatrists continue to have difficulty in educating their medical colleagues about the need to screen for these illnesses, so most obstetricians and pediatricians still do not screen for perinatal depression and anxiety, much less manage it effectively. Decisions about appropriate treatment are further complicated by a lack of empiric outcome data.


Scott T. Aaronson, MD

Latest:

Neurostimulation for Mood Disorders

We have medications that can affect serotonin, norepinephrine, and-to a lesser extent-dopamine. Many other neurotransmitters are involved with mood disorders, but we have no medications yet to target them. Neurostimulation offers a non-systemic somatic approach to depression, often with an improved side effect profile. More in this Q&A.


Scott Woods, MD

Latest:

Drs McGlashan and Woods Respond to Dr Feinberg

Dr Feinberg takes exception to much of what we wrote, or what he thinks we wrote, in our article “Early Antecedents and Detection in Schizophrenia”. We will do our best to reply to his criticisms of what we did write and try to point out where he is shadowboxing at issues that he has created but that we do not hold or endorse.


Scott Zeller, MD

Latest:

2025 Is a Landmark Year for Emergency Psychiatry

2025: one of the most consequential years ever for emergency psychiatry.


Sean Hood, MBBS, MSC

Latest:

SSRIs as Antihypertensives in Patients With Autonomic Panic Disorder

The cardiovascular properties of serotonin (5-HT) have been known for some time-its name reflects its presence in serum and its action in increasing vascular tone. Serotonergic medications are routinely used to treat depressive and anxiety disorders, and the association of depression with cardiovascular disease has become well established.2 Recent studies have confirmed the colloquial wisdom that anxiety (especially panic) and hypertension are linked.


Sean Hurdiss, MD

Latest:

A First-Episode Psychosis Treatment Program: “The Disease Doesn’t Define Me”

The Psychiatric Transition Program at the Naval Medical Center in San Diego is a specialized first-episode psychosis program that provides coordinated specialty care to active-duty service members with serious mental illness.


Sean Prabhu, MD

Latest:

Subtle Nuances in Diagnosis of Schizophrenia

An analysis of symptom severity across domains may enable us to reevaluate how we categorize symptoms within the spectrum of psychotic illness.


Sean Sassano-Higgins, MD

Latest:

My Patient Lost Their Job…Now What?

Unemployment is associated with an array of social and psychological complexities, directly affecting patients' self-esteem and perceptions of self-worth. When a patient loses their job, the psychiatrist has 4 tasks.


Sean Z. Kaliski, MB, BCh, PhD

Latest:

Impulse Control, Impulsivity, and Violence: Clinical Implications

The authors explore ways to address aggression in clinical practice and examine the potentially dangerous impulsivity-violence link across a broad range of conditions.


Sebastian Zimmerman, MD

Latest:

Intimate Portrait: Richard M. Berlin, MD

A brief psychological portrait of this psychiatrist/poet.

© 2025 MJH Life Sciences

All rights reserved.